Literature DB >> 3051881

Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP).

D Feldberg1, D Dicker, N Samuel, D Peleg, M Karp, J A Goldman.   

Abstract

Two groups of insulin-dependent diabetes mellitus (IDDM) parturients were managed according to different intrapartum protocols and compared with a control group of normal women in labor. Thirty-seven patients received conventional intensified insulin therapy during pregnancy and intravenous continuous insulin infusion during labor. Twenty-eight women were managed by continuous subcutaneous insulin infusion pump (CSIIP) throughout gestation and this therapeutic approach was continued during labor. When the two glucose control techniques were compared, CSIIP was superior to achieving and maintaining intrapartum optimal metabolic control, reducing significantly the incidence of acute fetal distress, thus lowering the cesarean section rate and neonatal hypoglycemia. Consequently we concur with the recommendation that firm prepartum as well as intrapartum diabetic control is mandatory for successful management of labor in IDDM patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3051881

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

Review 1.  The peripartum management of diabetes.

Authors:  Y Yap; A Modi; N Lucas
Journal:  BJA Educ       Date:  2019-11-26

Review 2.  Inpatient management of women with gestational and pregestational diabetes in pregnancy.

Authors:  Etoi A Garrison; Shubhada Jagasia
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

Review 3.  Glucose control during labor and delivery.

Authors:  Edmond A Ryan; Rany Al-Agha
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

4.  Diabetes and pregnancy: an endocrine society clinical practice guideline.

Authors:  Ian Blumer; Eran Hadar; David R Hadden; Lois Jovanovič; Jorge H Mestman; M Hassan Murad; Yariv Yogev
Journal:  J Clin Endocrinol Metab       Date:  2013-11       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.